1-3 of 3
Emma Jones
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait

Emma Jones, Sant-Rayn Pasricha, Angela Allen, Patricia Evans, Chris A. Fisher, Katherine Wray, Anuja Premawardhena, Dyananda Bandara, Ashok Perera, Craig Webster, Pamela Sturges, Nancy F. Olivieri, Timothy St. Pierre, Andrew E. Armitage, John B. Porter, David J. Weatherall, Hal Drakesmith
Journal: Blood
Blood (2015) 125 (5): 873–880.
https://doi.org/10.1182/blood-2014-10-606491
Published: 2015
Includes: Supplemental data
Journal Articles

Phase I Study of the JAK2 V617F Inhibitor, LY2784544, in Patients with Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Susanne Kloeker Rhoades, PhD, Jennifer L K Giles, BSc, Celine Pitou, PharmD, Emma Jones, PhD, Richard A Walgren, MD, PhD, Josef T. Prchal, MD
Journal: Blood
Blood (2011) 118 (21): 2814.
https://doi.org/10.1182/blood.V118.21.2814.2814
Published: 2011
Journal Articles

Use of Pharmacogenetic Factors to Predict Warfarin Dose in Children - a Retrospective Cohort Study

Emma Jones, MD, Mary Bauman, RN, BA, M. Patricia Massicotte, MD, Brian Gage, MD, Ebony Courtney, MA, Lisa Bomgaars, MD
Journal: Blood
Blood (2008) 112 (11): 988.
https://doi.org/10.1182/blood.V112.11.988.988
Published: 2008